Skip to search.
 TSX Up 0.48% TSX Ventures Up 1.12%

More On ENMD

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

(ENMD)

-NasdaqCM
1.71 Up 0.03(1.79%) Jun 13, 4:00PM EDT - Nasdaq Real Time Price
Add to Portfolio
Prev Close:N/A
Open:1.71
Bid:N/A
Ask:N/A
1y Target Est:1.00
Beta:2.31
Next Earnings Date:N/A
Day's Range:1.66 - 1.74
52wk Range:1.45 - 2.34
Volume:9,000
Avg Vol (3m):N/A
Market Cap:N/A
P/E (ttm):N/A
EPS (ttm):-0.22
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in .

Headlines

  • No Headlines available for ENMD at this time.

Comparison

Symbol% ChgMkt Cap
ENMDUp 1.79%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

EntreMed, Inc., a clinical-stage pharmaceutical company, develops therapeutics to treat cancer and other diseases primarily in the United States and China. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback